Workshop: In vitro cytokine-release assays

EventCorporate

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

Date

Reede, 20 november 2009, All day

Asukoht

European Medicines Agency, Amsterdam, the Netherlands

To predict cytokine release syndrome: The current state-of-the-science

Documents

Agenda - Workshop: In vitro Cytokine release assays; To predict Cytokine release syndrome: The current state-of-the-science

English (EN) (29.98 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Use of flow cytometry for investigating immunomodulatory effects of medicines: Richard Stebbings, NIBSC, England

English (EN) (32.23 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Evaluation of the Soluble and Solid Phase Cytokine Release Assay: Thomas Kawabata, Pfizer, St. Louis, MO.

English (EN) (41.82 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Development, validation and regulatory approval of a cytokine release test for contaminants: Peter Brà¼gger, Novartis, Switzerland.

English (EN) (15.53 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

The 24-hour whole-blood assay as potential in vitro tool to predict in vivo cytokine release following treatment with monoclonal antibodies

English (EN) (40.34 KB - PDF)

Esmakordselt avaldatud: Viimati ajakohastatud:
Vaata

Share this page